NCT04115254View on ClinicalTrials.gov

Stereotactic Magnetic Resonance Guided Radiation Therapy

NARecruitingINTERVENTIONAL
Enrollment

397

Participants

Timeline

Start Date

October 22, 2019

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2028

Conditions
Pancreas CancerLung CancerRenal CancerAdrenal MetastasesProstate CancerLiver MetastasesOligoprogressive Nodal MetastasesMetachronous Nodal MetastasesSynchronous Nodal MetastasesMesotheliomaSpine MetastasesBrain MetastasesBorderline Resectable Pancreatic Carcinoma
Interventions
RADIATION

MR-guided Linac

Radiation will be delivered on an MR-guided Linear Accelerator

Trial Locations (2)

02115

RECRUITING

Brigham & Women's Hospital, Boston

RECRUITING

Dana Farber Cancer Institute, Boston

All Listed Sponsors
lead

Dana-Farber Cancer Institute

OTHER

NCT04115254 - Stereotactic Magnetic Resonance Guided Radiation Therapy | Biotech Hunter | Biotech Hunter